Profile data is unavailable for this security.
About the company
Altamira Therapeutics Ltd. is a Bermuda-based company engaged in developing ribonucleic acid (RNA)-based therapeutics for extrahepatic targets (OligoPhore/SemaPhore delivery platforms). The Company has two flagship short interfering (siRNA) programs in preclinical development beyond in vivo proof of concept: AM-401 for KRAS driven cancer and AM-411 for rheumatoid arthritis. The delivery platform is also suited for messenger RNA (mRNA) and other types of RNA therapeutics and is focused to be leveraged via out-licensing to pharma or biotech companies. The therapeutic objective for AM-401 is to slow down KRAS driven tumor cell growth and proliferation or to stop it altogether by delivering siRNA specifically inside tumor cells for gene knock down. AM-411 is a polyplex nanoparticle delivering siRNA to inflamed tissues to target the NF-kB signaling pathway, a critical regulator of immune and inflammatory responses. Like AM-401, the drug product is based on its OligoPhore technology.
- Revenue in USD (TTM)59.60k
- Net income in USD-224.50k
- Incorporated2019
- Employees10.00
- LocationAltamira Therapeutics LtdClarendon House, 2 Church StreetHAMILTON 6300BermudaBMU
- Phone+41 612011350
- Websitehttps://aurismedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stemcell Holdings Inc | 9.98m | 3.10m | 1.64m | -- | -- | -- | 0.5008 | 0.1645 | 0.00008 | 0.00008 | 0.0003 | 0.0002 | 1.12 | -- | 5.20 | -- | 34.90 | -- | 68.19 | -- | 77.19 | -- | 31.04 | -- | -- | -- | 0.00 | -- | 85.10 | -- | 71.82 | -- | -- | -- |
Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 1.66m | 40.00 | -- | -- | -- | 0.6009 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
cbdMD Inc | 20.64m | -23.42m | 1.73m | 52.00 | -- | 0.5718 | -- | 0.0839 | -18.95 | -18.95 | 7.85 | 0.8055 | 0.8817 | 2.01 | 20.35 | 396,856.90 | -82.98 | -38.59 | -112.36 | -41.50 | 63.43 | 63.80 | -94.12 | -87.98 | 0.5172 | -3.89 | 0.3128 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
Link Reservations Inc | 0.00 | -480.90k | 1.74m | 0.00 | -- | -- | -- | -- | -46.51 | -46.51 | 0.00 | -13.99 | 0.00 | -- | -- | -- | -246.84 | -- | -- | -- | -- | -- | -- | -- | -- | -2.43 | -- | -- | -- | -- | -22.69 | -- | -- | -- |
InVitro International | 716.89k | 6.22k | 1.82m | 16.00 | 228.57 | 2.49 | -- | 2.54 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
Psyence Biomedical Ltd | 0.00 | 1.52m | 1.82m | -- | -- | -- | 1.20 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
Agentix Corp | 0.00 | -326.32k | 2.00m | -- | -- | -- | -- | -- | -0.0081 | -0.0081 | 0.00 | -0.068 | 0.00 | -- | -- | -- | -131.20 | -- | -- | -- | -- | -- | -- | -- | -- | -16.66 | -- | -- | -- | -- | 57.41 | -- | -- | -- |
Scisparc Ltd | 0.00 | -6.96m | 2.27m | 3.00 | -- | 6.36 | -- | -- | -1.22 | -1.51 | 0.00 | 0.0344 | 0.00 | -- | -- | 0.00 | -92.51 | -69.39 | -152.41 | -111.07 | -- | -- | -- | -527.17 | -- | -- | 0.9371 | -- | 113.73 | -- | -97.61 | -- | -- | -- |
SOHM Inc | -100.00bn | -100.00bn | 2.29m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Vestiage Inc | 0.00 | -39.63k | 2.32m | 0.00 | -- | -- | -- | -- | -0.0007 | -0.0007 | 0.00 | -0.0015 | 0.00 | -- | -- | -- | -12,384.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -102.30 | -- | -- | -- |
Scorpius Holdings Inc | 9.85m | -29.57m | 2.34m | 82.00 | -- | 0.0144 | -- | 0.2374 | -183.17 | -200.56 | 53.89 | 51.92 | 0.1552 | -- | 11.08 | 120,061.60 | -49.90 | -39.37 | -59.65 | -43.18 | 64.27 | -- | -321.53 | -1,068.21 | 0.3127 | -43.94 | 0.3569 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
Altamira Therapeutics Ltd | 59.60k | -224.50k | 2.40m | 10.00 | 0.9355 | 0.2684 | -- | 40.26 | 0.6788 | 0.6788 | 0.0337 | 2.37 | 0.008 | -0.1997 | 3.36 | 5,960.18 | -2.99 | -66.27 | -5.77 | -113.27 | 150.61 | -- | -376.67 | -25,125.90 | 0.4268 | -- | 0.0634 | -- | -- | -- | 89.86 | -- | -- | -- |
Shuttle Pharmaceuticals Holdings Inc | 0.00 | -7.20m | 2.43m | 8.00 | -- | 0.3581 | -- | -- | -10.29 | -10.29 | 0.00 | 3.04 | 0.00 | -- | -- | 0.00 | -123.53 | -- | -147.27 | -- | -- | -- | -- | -- | -- | -4.32 | 0.5076 | -- | -- | -- | -112.71 | -- | -- | -- |
Nexien Biopharma Inc | 0.00 | -246.18k | 2.89m | 0.00 | -- | -- | -- | -- | -0.0038 | -0.0038 | 0.00 | -0.0048 | 0.00 | -- | -- | -- | -679.40 | -860.53 | -- | -1,653.53 | -- | -- | -- | -- | -- | -1.77 | -- | -- | -- | -- | 42.22 | -- | -- | -- |
Sonnet Biotherapeutics Holdings Inc | 55.89k | -7.99m | 3.17m | 12.00 | -- | 1.22 | -- | 56.78 | -24.17 | -24.17 | 0.1156 | 4.01 | 0.0071 | -- | 0.0881 | 4,657.50 | -100.88 | -- | -255.30 | -- | -- | -- | -14,287.67 | -- | -- | -331.07 | 0.00 | -- | -57.76 | -- | 36.64 | -- | -- | -- |
Holder | Shares | % Held |
---|---|---|
Tower Research Capital LLCas of 31 Mar 2024 | 1.66k | 0.07% |
Group One Trading LPas of 31 Mar 2024 | 14.00 | 0.00% |
LRI Investments LLCas of 30 Jun 2024 | 1.00 | 0.00% |
Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 0.00 | 0.00% |
UBS Securities LLCas of 31 Mar 2024 | 0.00 | 0.00% |